Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Type of information:
experimental study
Adequacy of study:
key study
Study period:
02 Sep 2004 to 03 Dec 2004
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2005
Report date:
2005

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
Version / remarks:
(adopted 1997)
Deviations:
no
GLP compliance:
yes
Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Chemical structure
Reference substance name:
Hexadecyltrimethoxysilane
EC Number:
240-464-3
EC Name:
Hexadecyltrimethoxysilane
Cas Number:
16415-12-6
Molecular formula:
C19H42O3Si
IUPAC Name:
Hexadecyl(trimethoxy)silane
Test material form:
other: liquid
Details on test material:
- Name of test material (as cited in study report): Dynasylan 9116
- Physical state: colourless liquid
- Expiration date of the lot/batch: 06 Aug 2005
- Storage condition of test material: ambient temperature

Method

Target gene:
Not applicable
Species / strain
Species / strain / cell type:
Chinese hamster Ovary (CHO)
Metabolic activation:
with and without
Metabolic activation system:
phenobarbital and beta-naphthoflavone induced rat liver S9
Test concentrations with justification for top dose:
Experiment I:
- 10.2, 20.3, 40.6, 81.3, 163, 325, 650 and 1300 µg/ml (with and without metabolic activation)
Experiment II:
- 10.2, 20.3, 40.6, 81.3, 163, 325, 650 and 1300 µg/ml (with and without metabolic activation)
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: ethanol
- Justification for choice of solvent/vehicle: Solubility properties and relative non-toxicity to cells
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: -S9-mix: mitomycin C: 0.3 µg/ml (3 h treatment), 0.1 µg/ml (20 h treatment); +S9-mix: cyclophosphamide: 15 µg/ml (3 h treatment)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION
- Preincubation period:
- Exposure duration: 3 h and 20 h
- Fixation time (start of exposure up to fixation or harvest of cells): 20 h

SPINDLE INHIBITOR (cytogenetic assays): colcemid (0.2 µg/ml; added 3 hours before harvest)

STAIN (for cytogenetic assays): Giemsa (3%)

NUMBER OF REPLICATIONS: 2 independent experiment

NUMBER OF CELLS EVALUATED: 100 cells from each culture were evaluated for chromosome abberations.

DETERMINATION OF CYTOTOXICITY
- Method: relative cell count

Evaluation criteria:
The test item is considered to have clastogenic properties if there is a statistically significant increase in the incidence of cells bearing aberrations at any dose level over the concurrent control. The increase must exceed historical control values. The increases must be reproduced in both cultures.
Statistics:
Where necessary, the frequency of cells with aberrations excluding gaps, and the frequency of polyploid cells was compared with the concurrent vehicle control using Fischer's Exact test.

Results and discussion

Test results
Species / strain:
Chinese hamster Ovary (CHO)
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
Experiment 1: cytotoxicity at 650 µg/mL (+S9) and 1300 µg/mL (±S9); Experiment 2: cytotoxicity at 10.2, 20.3 and 40.6 µg/mL (-S9). Precipitation was observed in the culture medium at 650 and 1300 µg/mL at the start and end of treatment.
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
Full study data tables are attached and summarized data is provided in the field "Any other information on results incl. tables".

CYTOTOXICITY:
- In Experiment 1 in the absence of S9, slight toxicity was observed at 1300 µg/mL, with the cell count reduced to 74% of the control value. No relevant toxicity was observed for the remaining dose levels.
- In Experiment 1 in the presence of S9, slight toxicity was seen at 650 and 1300 µg/mL, with the cell counts reduced to 75% and 70% of the controls respectively.
- In Experiment 2 in the absence of S9, severe toxicity was seen at 81.3 to 1300 µg/mL, with few or no cells observed. Moderate toxicity was observed at 20.3 and 40.6 µg/mL, with cells counts reduced to 51 and 34% of the controls respectively. Mild toxicity was observed at the lowest dose level of 10.2 µg/mL, with the cell count reduced to 65% of the control.

GENOTOXICITY
- For both Experiment 1 and Experiment 2 there were no statistically significant increases in the incidence of cells bearing aberrations (including and excluding gaps).
- In Experiment 1, no relevant increase in the incidence of cells bearing aberrations (including or excluding gaps) over the control value was observed.
- In Experiment 2, a slight increase in the incidence of cells bearing aberrations (including or excluding gaps) over the control value was observed at the intermediate dose level (20.3 µg/mL). This however was not considered as biologically meaningful since the incidence was within the range of the historical controls and corresponded to the concurrent value for the untreated controls.

POSITIVE CONTROLS
- Statistically significant increases in the frequency of cells bearing aberrations (including and excluding gaps) were seen for the positive control substances, indicating the correct functioning of the assay system.

COMPARISON WITH HISTORICAL CONTROL DATA: Results were within range of historical control data (see attached data tables).

Any other information on results incl. tables

Table 2: Results of chromosome analysis Experiment 1, 3h treatment without activation (total count from 2 cultures)






































































































 



Untreated


***



Solvent*


Control***



Positive


Control**



Low dose***



Mid dose***



High dose***



 



Mean



Chromatid aberrations



gaps



0



0



3



0



0



1



deletions



0



0



25



0



0



0



interchanges



0



0



49



0



0



0



Chromosome aberrations



gaps



NR



NR



NR



NR



NR



NR



deletions



0



0



3



0



0



0



interchanges



0



0



0



0



0



0



Mitotic index



NR



NR



NR



NR



NR



NR



Polyploidy



0



0



0



0



0



0



Endo reduplication



0



0



0



0



0



0



 *Solvent control with ethanol


** Per 150 cells


*** Per 200 cells


NR not reported


 


Table 3: Results of chromosome analysis Experiment 1, 3h treatment with activation (total count from 2 cultures)






































































































 



Untreated


***



Solvent*


Control***



Positive


Control**



Low dose***



Mid dose***



High dose***



 



Mean



Chromatid aberrations



gaps



0



0



3



0



0



1



deletions



0



0



25



1



0



22



interchanges



0



0



49



0



0



40



Chromosome aberrations



gaps



NR



NR



NR



NR



NR



NR



deletions



0



0



3



0



0



5



interchanges



0



0



0



0



0



0



Mitotic index



NR



NR



NR



NR



NR



NR



Polyploidy



0



0



0



0



0



0



Endo reduplication



2



0



0



0



0



0



 *Solvent control with ethanol


** Per 150 cells


*** Per 200 cells


NR not reported


 


Table 4: Results of chromosome analysis Experiment 2, 20h treatment without activation (total count from 2 cultures)






































































































 



Untreated


***



Solvent*


Control***



Positive


Control**



Low dose***



Mid dose***



High dose***



 



Mean



Chromatid aberrations



gaps



0



0



0



0



0



1



deletions



1



1



7



1



1



0



interchanges



4



0



52



0



1



0



Chromosome aberrations



gaps



NR



NR



NR



NR



NR



NR



deletions



0



0



9



2



3



0



interchanges



0



0



0



0



0



0



Mitotic index



NR



NR



NR



NR



NR



NR



Polyploidy



0



0



0



0



0



0



Endo reduplication



0



0



0



0



0



0



 *Solvent control with ethanol


** Per 150 cells


*** Per 200 cells


NR not reported


 

Applicant's summary and conclusion

Conclusions:
Interpretation of results:
negative

The substance was tested to OECD 473 (1997) under GLP. The test material did not induce any statistically significant, dose-related increases in the frequency of cells with chromosomal aberrations either in the presence or absence of metabolic activation or after various exposure times. The test material was therefore considered to be non-clastogenic to CHO cells in vitro under the conditions of the test.